IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Paradigm Biocapital Advisors LP

Q2 2025 Holdings

Filed 2025-08-14 | 28 holdings | $2.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Nuvalent Inc(NUVL)COM670703107$402.1M5,269,43317.2%
Arcellx Inc(ACLX)COMMON STOCK03940C100$306.1M4,649,01613.1%
Merus N VCOMN5749R100$225.2M4,281,9549.6%
Revolution Medicines Inc(RVMD)COM76155X100$224.2M6,093,2919.6%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$120.6M2,976,0995.1%
Vaxcyte Inc(PCVX)COM92243G108$109.7M3,372,8374.7%
Beone Medicines LTD(ONC)SPONSORED ADS07725L102$84.2M347,7873.6%
Edgewise Therapeutics Inc(EWTX)COM28036F105$80.5M6,142,3443.4%
Cogent Biosciences Inc(COGT)COM19240Q201$74.3M10,352,4493.2%
Janux Therapeutics Inc(JANX)COM47103J105$67.5M2,920,2582.9%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$67.4M2,343,5532.9%
Disc Medicine Inc(IRON)COM254604101$64.1M1,210,9712.7%
Scholar Rock Hldg Corp(SRRK)COM80706P103$56.7M1,600,5542.4%
Lenz Therapeutics Inc(LENZ)COM52635N103$50.3M1,717,0662.1%
Bridgebio Pharma Inc(BBIO)COM10806X102$41.7M965,7641.8%
Apogee Therapeutics Inc(APGE)COM03770N101$41.6M958,6301.8%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$41.5M878,3231.8%
Alkermes PLC(ALKS)SHSG01767105$39.4M1,375,5691.7%
Viridian Therapeutics Inc(VRDN)COM92790C104$38.3M2,741,5761.6%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$38.0M1,142,5111.6%
Ocular Therapeutix Inc(OCUL)COM67576A100$31.7M3,420,3401.4%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$28.8M6,764,1721.2%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$28.0M1,870,4451.2%
Y-Mabs Therapeutics Inc(YMABUSD)COM984241109$19.1M4,236,3460.8%
Pharvaris N V(PHVS)COMN69605108$18.7M1,062,9110.8%
Immatics N.v(IMTX)SHSN44445109$16.9M3,144,1570.7%
Erasca Inc(ERAS)COM29479A108$15.1M11,907,1820.6%
Crescent Biopharma Inc.(CBIO)COMG2545C104$10.4M642,7210.4%